| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Sharon R Grady, Karen L Murphy, Jian Cao, Michael J Marks, J Michael McIntosh, Allan C Collin. Characterization of nicotinic agonist-induced [(3)H]dopamine release from synaptosomes prepared from four mouse brain regions. The Journal of pharmacology and experimental therapeutics. vol 301. issue 2. 2002-05-13. PMID:11961070. |
release studies in frontal cortex indicated that in this region only dopaminergic and noradrenergic terminals are capable of packaging [(3)h]dopamine in a form allowing vesicle-mediated release; additionally, only the dopaminergic terminals have functional presynaptic nachrs that, when stimulated by nicotinic agonists, evoke [(3)h]dopamine release. |
2002-05-13 |
2023-08-12 |
mouse |
| Carmen Guerrero, Liuska Pesce, Emilia Lecuona, Karen M Ridge, Jacob I Sznajde. Dopamine activates ERKs in alveolar epithelial cells via Ras-PKC-dependent and Grb2/Sos-independent mechanisms. American journal of physiology. Lung cellular and molecular physiology. vol 282. issue 5. 2002-05-09. PMID:11943676. |
recently it has been described that dopamine (da), via dopaminergic type 2 receptors (d(2)r), activates the mitogen-activated protein kinase extracellular signal-regulated kinase (mapk/erk) proteins in alveolar epithelial cells (aec), which results in the upregulation of na(+)-k(+)-atpase. |
2002-05-09 |
2023-08-12 |
Not clear |
| Alexander Storch, Stefanie Ott, Yu I Hwang, Rainer Ortmann, Andreas Hein, Stefan Frenzel, Kazuo Matsubara, Shigeru Ohta, Hans Uwe Wolf, Johannes Schwar. Selective dopaminergic neurotoxicity of isoquinoline derivatives related to Parkinson's disease: studies using heterologous expression systems of the dopamine transporter. Biochemical pharmacology. vol 63. issue 5. 2002-05-07. PMID:11911843. |
selective dopaminergic neurotoxicity of isoquinoline derivatives related to parkinson's disease: studies using heterologous expression systems of the dopamine transporter. |
2002-05-07 |
2023-08-12 |
mouse |
| J K Melichar, M R Daglish, D J Nut. Addiction and withdrawal--current views. Current opinion in pharmacology. vol 1. issue 1. 2002-05-06. PMID:11712541. |
the final common pathway of addiction (the dopamine hypothesis of reward) has recently been evolving, with the mesocorticolimbic dopaminergic system now seen as key to natural rewards and drug-seeking behaviour, though perhaps having less of a role in the maintenance of such behaviour. |
2002-05-06 |
2023-08-12 |
Not clear |
| B Payá, J A Guisado, F J Vaz, B Crespo-Facorr. Visual hallucinations induced by the combination of prolintane and diphenhydramine. Pharmacopsychiatry. vol 35. issue 1. 2002-05-03. PMID:11819155. |
an increase in dopaminergic brain activity is proposed as the causal mechanism for hallucinations--whereas prolintane can induce the release of dopamine at the synaptic cleft, diphenhydramine can act inhibiting the reuptake of dopamine and inducing a potentiation of its effects. |
2002-05-03 |
2023-08-12 |
Not clear |
| Monique P Curran, Caroline M Perr. Spotlight on amisulpride in schizophrenia. CNS drugs. vol 16. issue 3. 2002-05-03. PMID:11888341. |
at low doses, it enhances dopaminergic neurotransmission by preferentially blocking presynaptic dopamine d(2)/d(3) autoreceptors. |
2002-05-03 |
2023-08-12 |
Not clear |
| Orlan Youngren, Yupaporn Chaiseha, Khaled Al-Zailaie, Stephen Whiting, Seong Wook Kang, Mohamed El Halawan. Regulation of prolactin secretion by dopamine at the level of the hypothalamus in the turkey. Neuroendocrinology. vol 75. issue 3. 2002-05-03. PMID:11914590. |
dynorphin, serotonin (5-ht), dopamine (da) and vip all appear to stimulate prl secretion along a hypothalamic pathway, expressing kappa opioid, serotonergic, dopaminergic and vipergic receptors in succession, with the vipergic system as the final mediator. |
2002-05-03 |
2023-08-12 |
Not clear |
| A A Lerant, J E DeMaria, M E Freema. Decreased expression of fos-related antigens (FRAs) in the hypothalamic dopaminergic neurons after immunoneutralization of endogenous prolactin. Endocrine. vol 16. issue 3. 2002-05-02. PMID:11954661. |
in our previous studies we found that administration of exogenous prolactin increased dopamine turnover in the terminal areas of the hypothalamic dopaminergic neurons controlling prolactin secretion from pituitary lactotrophs. |
2002-05-02 |
2023-08-12 |
rat |
| A Kupsch, J Sautter, M E Götz, W Breithaupt, J Schwarz, M B Youdim, P Riederer, M Gerlach, W H Oerte. Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline. Journal of neural transmission (Vienna, Austria : 1996). vol 108. issue 8-9. 2002-04-29. PMID:11716151. |
40%) of dopaminergic (tyrosine-hydroxylase-positive) cells in the substantia nigra, pars compacta; and 3. putaminal dopamine depletion of 98% and its metabolites dopac (88%) and hva (96%). |
2002-04-29 |
2023-08-12 |
mouse |
| A Kupsch, J Sautter, M E Götz, W Breithaupt, J Schwarz, M B Youdim, P Riederer, M Gerlach, W H Oerte. Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline. Journal of neural transmission (Vienna, Austria : 1996). vol 108. issue 8-9. 2002-04-29. PMID:11716151. |
there were no significant differences between rasagiline/mptp and selegiline/mptp-treated animals in respect to signs of motor impairment, the number of dopaminergic cells in the substantia nigra, and striatal dopamine levels. |
2002-04-29 |
2023-08-12 |
mouse |
| V Laurent, A Kimble, B Peng, P Zhu, J E Pintar, D F Steiner, I Lindber. Mortality in 7B2 null mice can be rescued by adrenalectomy: involvement of dopamine in ACTH hypersecretion. Proceedings of the National Academy of Sciences of the United States of America. vol 99. issue 5. 2002-04-26. PMID:11854475. |
because hypothalamic inhibitory dopaminergic control represents the major influence on intermediate lobe proopiomelanocortin-derived peptide secretion, dopamine levels were measured, and they revealed that 7b2 null pituitaries contained only one-fourth of wt pituitary dopamine. |
2002-04-26 |
2023-08-12 |
mouse |
| Qin Zhou, Fred Nyber. Injection of substance P (SP) N-terminal fragment SP(1-7) into the ventral tegmental area modulates the levels of nucleus accumbens dopamine and dihydroxyphenylacetic acid in male rats during morphine withdrawal. Neuroscience letters. vol 320. issue 3. 2002-04-25. PMID:11852176. |
although all these processes are believed to be associated with dopaminergic transmission no evidence of an interaction between sp(1-7) and dopamine in the case of morphine withdrawal has so far been reported. |
2002-04-25 |
2023-08-12 |
rat |
| R K Sharm. Development and survival of tyrosine hydroxylase containing neurons in RCS rat retinae. Current eye research. vol 23. issue 4. 2002-04-22. PMID:11852426. |
dopaminergic amacrine cells respond to light by increasing their tyrosine hydroxylase (th) activity and the rate of dopamine turnover. |
2002-04-22 |
2023-08-12 |
rat |
| Maria-Joao Ribeiro, Marie Vidailhet, Christian Loc'h, Corinne Dupel, Jean Paul Nguyen, Michel Ponchant, Frédéric Dollé, Marc Peschanski, Philippe Hantraye, Pierre Cesaro, Yves Samson, Philippe Rem. Dopaminergic function and dopamine transporter binding assessed with positron emission tomography in Parkinson disease. Archives of neurology. vol 59. issue 4. 2002-04-19. PMID:11939892. |
dopaminergic function and dopamine transporter binding assessed with positron emission tomography in parkinson disease. |
2002-04-19 |
2023-08-12 |
Not clear |
| Maria-Joao Ribeiro, Marie Vidailhet, Christian Loc'h, Corinne Dupel, Jean Paul Nguyen, Michel Ponchant, Frédéric Dollé, Marc Peschanski, Philippe Hantraye, Pierre Cesaro, Yves Samson, Philippe Rem. Dopaminergic function and dopamine transporter binding assessed with positron emission tomography in Parkinson disease. Archives of neurology. vol 59. issue 4. 2002-04-19. PMID:11939892. |
to date, (18)f-dopa has been the gold standard to measure presynaptic dopaminergic function in pd, but this tracer might overestimate the rate of neuronal death in pd because its uptake also depends on dopamine turnover rather than exclusively on the density of dopaminergic terminals in the striatum. |
2002-04-19 |
2023-08-12 |
Not clear |
| J S Yun, H S Kim, M K Lee, K W Oh, C G Jang, W K Park, Y H Seong, S C Lee, S K O. Inhibitory effects of MK-801 on contextual sensitization to climbing behavior and on development of tolerance to hypothermia induced by a single high dose of apomorphine. Pharmacological research. vol 44. issue 6. 2002-04-15. PMID:11735353. |
these results suggest that mk-801 inhibited contextual sensitization to climbing behavior and development of tolerance to hypothermia through glutamatergic modulation of dopaminergic functions at dopamine receptors. |
2002-04-15 |
2023-08-12 |
Not clear |
| Michele Hummel, Ellen M Unterwal. D1 dopamine receptor: a putative neurochemical and behavioral link to cocaine action. Journal of cellular physiology. vol 191. issue 1. 2002-04-15. PMID:11920678. |
in light of cocaine's multifarious effects on numerous neuronal systems, its effect on dopaminergic neurotransmission has attracted the most attention, particularly because of the implicated role of dopamine in brain reward. |
2002-04-15 |
2023-08-12 |
Not clear |
| S Porat, A Premkumar, R Simanto. Dopamine induces phenotypic differentiation or apoptosis in a dose-dependent fashion: involvement of the dopamine transporter and p53. Developmental neuroscience. vol 23. issue 6. 2002-04-12. PMID:11872944. |
these findings provide an insight into the role of dopamine, dopamine transporters and p53 in the differentiation and apoptosis of dopaminergic neurons, which will further our understanding of neuronal development and neurodegenerative diseases. |
2002-04-12 |
2023-08-12 |
human |
| K Biglan, R G Hollowa. Initial treatment of early Parkinson's disease: a review of recent, randomized controlled trials. Current neurology and neuroscience reports. vol 1. issue 4. 2002-04-09. PMID:11898538. |
however, levodopa was more frequently associated with dopaminergic motor complications, and the dopamine agonists were more commonly associated with adverse events. |
2002-04-09 |
2023-08-12 |
Not clear |
| Christine A Gleason, Roderick Robinson, Andrew P Harris, Dennis E Mayock, Richard J Traystma. Cerebrovascular effects of intravenous dopamine infusions in fetal sheep. Journal of applied physiology (Bethesda, Md. : 1985). vol 92. issue 2. 2002-04-08. PMID:11796686. |
we tested these responses to dopamine in 11 additional near-term fetuses under alpha-adrenergic blockade (phenoxybenzamine, n = 5) and under dopaminergic d(1)-receptor blockade (sch-23390, n = 6). |
2002-04-08 |
2023-08-12 |
Not clear |